An evaluation of the safety of a low-saturated-fat, low-cholesterol diet beginning in infancy

Pediatrics
|November 1, 1976
PubMed

Insights

Children on a lifelong low-saturated-fat, low-cholesterol (LSFLC) diet showed no adverse developmental or somatic differences by age 3. Their serum cholesterol was lower, but other health markers remained comparable to controls.

Area of Science:

  • Pediatric Nutrition
  • Developmental Pediatrics
  • Clinical Chemistry

Background:

  • Dietary fat intake in early childhood is a key area of nutritional research.
  • Understanding the long-term effects of specific dietary patterns, like low-saturated-fat, low-cholesterol (LSFLC) diets, is crucial for child health.
  • Assessing potential impacts on growth, development, and metabolic markers is essential.

Purpose of the Study:

  • To investigate potential developmental, body chemistry, and somatic differences in children following an LSFLC diet since birth.
  • To compare these children to a matched control group at three years of age.
  • To evaluate the safety and efficacy of early-life adherence to an LSFLC diet.

Main Methods:

  • A cohort of children on an LSFLC diet since birth was compared to a matched control group at age 3.
  • Key parameters assessed included percentile height, weight, head circumference, skinfold thickness, and hemoglobin.
  • Developmental milestones were evaluated using the Denver Developmental Screening test, alongside serum cholesterol and total serum protein levels.

Main Results:

  • No significant differences were observed between the LSFLC and control groups in percentile height, weight, head circumference, skinfold thickness, total serum protein, hemoglobin, developmental screening, or sick visits.
  • Children on the LSFLC diet exhibited significantly lower serum cholesterol levels compared to a larger reference group.
  • The study found no significant adverse health findings in the LSFLC group at age 3.

Conclusions:

  • Adherence to an LSFLC diet from birth up to age 3 years does not appear to result in significant adverse developmental or somatic outcomes.
  • Lower serum cholesterol levels in the LSFLC group suggest dietary efficacy in cholesterol reduction.
  • The findings support the safety of early-life implementation of LSFLC diets in children.

Related Concept Videos

Lipid Digestion01:16

Lipid Digestion

Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...